136 related articles for article (PubMed ID: 3732982)
21. Management of the patient with acute stroke.
Greer M
Geriatrics; 1973 Dec; 28(12):48-53. PubMed ID: 4758650
[No Abstract] [Full Text] [Related]
22. [Conservative therapy of peripheral arterial occlusive diseases].
Alexander K
Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
[TBL] [Abstract][Full Text] [Related]
23. [Hemodilution therapy in peripheral arterial occlusive disease].
Internist (Berl); 1992 May; 33(5 Suppl [HAMODILU]):1-8. PubMed ID: 1618610
[No Abstract] [Full Text] [Related]
24. [Video capillary microscopy studies of probands without and with occlusions of the finger arteries before and following hyper- and isovolemic hemodilution].
Schmidtke S; Rieger H
Vasa Suppl; 1991; 32():229-32. PubMed ID: 1771502
[No Abstract] [Full Text] [Related]
25. [Hemodilution therapy of arterial occlusive diseases using hydroxyethyl starch 200/0,5].
Müller-Bühl U; Comberg HU; Diehm C; Allenberg J; Mörl H
MMW Munch Med Wochenschr; 1982 Mar; 124(10):241-3. PubMed ID: 6178019
[No Abstract] [Full Text] [Related]
26. [Late results of conservative therapy of arterial occlusive diseases].
Schoop W
Internist (Berl); 1984 Jul; 25(7):429-33. PubMed ID: 6236161
[No Abstract] [Full Text] [Related]
27. Isovolemic hemodilution as a functional therapy of decompensated arteriosclerotic stenoses of the femoral, cerebral and ophthalmic artery.
Schmid-Schönbein H; Rieger H
Ric Clin Lab; 1983; 13 Suppl 3():29-52. PubMed ID: 6673004
[TBL] [Abstract][Full Text] [Related]
28. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
29. [Hemodilution in arterial occlusive diseases].
Rieger H
Verh Dtsch Ges Inn Med; 1981; 87():1348-53. PubMed ID: 7331426
[No Abstract] [Full Text] [Related]
30. [Isovolemic hemodilution in peripheral arterial occlusive diseases].
Ernst E; Matrai A
Dtsch Med Wochenschr; 1986 Oct; 111(43):1661-2. PubMed ID: 3769813
[No Abstract] [Full Text] [Related]
31. [Treatment of stroke].
Nagazumi A
Nihon Ika Daigaku Zasshi; 1993 Oct; 60(5):353-9. PubMed ID: 8253911
[No Abstract] [Full Text] [Related]
32. Indications and contraindications of isovolemic hemodilution in clinical angiology.
Rieger H
Bibl Haematol; 1981; (47):149-56. PubMed ID: 7337657
[No Abstract] [Full Text] [Related]
33. [Arterial thromboembolectomy and fibrinolytics].
Basile M; Celi S; Mandolfino T; Grasso V; Magri E
Minerva Chir; 1982 Oct; 37(20):1745-6. PubMed ID: 7177423
[No Abstract] [Full Text] [Related]
34. The results of arterial thrombolysis.
Kroese AJ; Staxrud LE
Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
[No Abstract] [Full Text] [Related]
35. [Medical treatment of arteriopathies of the lower extremities].
Juillet Y
Soins; 1981 Oct; 26(20):23-8. PubMed ID: 6916466
[No Abstract] [Full Text] [Related]
36. [Current internal therapy in arterial occlusive diseases].
Marshall M
ZFA (Stuttgart); 1980 Sep; 56(26):1625-33. PubMed ID: 7456655
[No Abstract] [Full Text] [Related]
37. Combined thrombolytic and Dotter treatment in arterial occlusive disease.
Eie H; Ro J; Amundsen E; Osvik K
J Oslo City Hosp; 1972; 22(9):141-8. PubMed ID: 5075930
[No Abstract] [Full Text] [Related]
38. Peripheral arterial diseases.
Verstraete M; Vermylen J; Verhaeghe RH
Clin Haematol; 1981 Jun; 10(2):669-89. PubMed ID: 6459202
[No Abstract] [Full Text] [Related]
39. [Clinical use of thrombolytic agents].
Laprevote-Heully MC; Lambert H; Larcan A
Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
[No Abstract] [Full Text] [Related]
40. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
Ott E; Lechner H
Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
